Category Archives: HIV/Aids

H.I.V. Cases Surpass a Million in Russia, but Little Is Done

By Neil MacFarquhar, The New York Times | December 28, 2016 PETERSBURG, Russia — Quietly, the number of Russians who have received a positive H.I.V. diagnosis passed the one million mark this year. There is, however, little indication that the … Continue reading

Posted in HIV/Aids, Uncategorized | Tagged | Leave a comment

On World AIDS Day, threat to access to medicines looms large

By Shailly Gupta, Jakarta Post| December 2, 2016 Today millions of people living with HIV in South-East Asia are receiving treatment and leading healthy lives thanks to affordable generic antiretroviral (ARVs) medicines. Governments and treatment providers across Asia, such as … Continue reading

Posted in Generics, HIV/Aids, IPR, Regional Comprehensive Economic Partnership, Tuberculosis (TB), Uncategorized | Leave a comment

DNP+ demands strengthening of HIV/AIDS (Prevention and Control) Bill

  Don’t Turn Back on Right to Treatment 25 November, 2016 The HIV/AIDS Bill is a unique achievement in public health legislation seeking to benefit millions of people living with and vulnerable to the disease.  It seeks to address HIV/AIDS … Continue reading

Posted in HIV/Aids, HIV/AIDS Bill | Leave a comment

German Court Issues Compulsory License on HIV Drug Patent

Submitted by Andrew Goldman on 8. September 2016, Knowledge Ecology International A German patent court has ordered a compulsory license under Section 24 of the Patent Act, allowing Merck (US) to continue to market the HIV drug raltegravir (marketed as … Continue reading

Posted in Compulsory Licensing, HIV/Aids, Uncategorized | Leave a comment

AIDS activists demand treatment for all

By Anika Richards, Jamaica Observer| July 18, 2016 DURBAN, South Africa — As the world observed Nelson Mandela International Day, thousands of civil rights activists from South Africa and across the world took to the streets of Durban, South Africa, … Continue reading

Posted in HIV/Aids, Uncategorized | Leave a comment

The new pharma FDI policy undermines Indian generics, which may make drugs more expensive

By relaxing brownfield pharma FDI norms, the government is making way for multinational corporations to take over ‘Make in India’ generics companies. By Leena Menghaney, The Scroll | June 28, 2016 The Union government’s decision to allow up to 74% … Continue reading

Posted in FDI, Generics, HIV/Aids, Uncategorized | Leave a comment

The Medicines Patent Pool Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines

Medicines Patent Pool; December 1, 2015. Geneva – The Medicines Patent Pool (MPP) today announced a collaboration with the University of Liverpool and a licence for the university’s Solid Drug Nanoparticle (SDN) technology to accelerate the development of WHO-recommended antiretrovirals as nanomedicines. The … Continue reading

Posted in HIV/Aids, Medicine Patent Pool, Public research | Leave a comment